China Life: cheap valuation?

Will a large issue size and reliance on institutional participation necessitate a compelling valuation for the IPO?

Pre-marketing for a 6.47 billion share offering pre greenshoe in China Life began last Friday under the lead management of CICC, Citigroup, Credit Suisse First Boston and Deutsche Bank.

Regulatory delays mean the $1.9 billion to $3.2 billion deal is now on an accelerated timetable to make sure it begins trading before Christmas. Formal roadshows are scheduled for December 1 and institutional pricing for December 11, followed by trading in New York on December 16 and Hong Kong on December 17.

China Life should represent the world's biggest IPO this year. But does the combination of a large issue size, late timing, and lack of investor awareness suggest the need...

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222